05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances; pharmaceutical preparations and substances for diagnosis; pharmaceutical preparations and substances for therapy and treatment; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals; radioprotectors; radiopharmaceuticals for use in theranostics; radiopharmaceutical products; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes; radiopharmaceuticals for medical and clinical use; radiopharmaceutical sources and norms for nuclear medicine; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes; diagnostic and therapeutic radioisotopes and radiochemicals for medical purposes; radiopharmaceutical preparations and substances for endo-radionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics in the field of oncology; theranostics in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule; preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material; to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for diagnostic applications; chemicals for pharmaceutical use; chemicals for radiopharmaceuticals for diagnostic uses; pharmaceutical drugs; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; radioactive pharmaceutical preparations; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; implantable radiotherapy devices; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use; positron emission tomography tracers for medical use; positron emission tomography tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; preparations for use in molecular imaging (for medical use); radiotherapeutic preparations; radiodiagnostic preparations; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes; radiopharmaceuticals and radioactive marked substances for therapeutic purposes; solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances for medical imaging; scanning diagnostic reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemicals for medical purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for diagnostic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for therapeutic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for the diagnosis of cancer; drug delivery agents for facilitating delivery of pharmaceutical agents for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals to diagnose and treat cancer; radiopharmaceutical imaging agents for selecting cancer treatments; radiopharmaceutical detection agents for selecting cancer treatments; radiopharmaceutical imaging and detection agents for selecting cancer treatments; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of diseases; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products preparations in the treatment of oncological diseases; tumor-seeking tracers for use in medical imaging; molecular-imaging probes for diagnostic purposes Radiotherapy apparatus and instruments; implantable radioactive sources of radiation; instruments and apparatus for immunotherapy and immuno-diagnostics; medical test equipment; blood analysers; diagnostic devices for medical purposes; electrodes for medical purposes; injection syringes; instrument cases for use by doctors and surgeons; special cases for medical instruments; masks for medical staff; medical apparatus and instruments, namely for the manufacture of radionuclides; pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers for protection against ionising radiation for medical use; insulated containers for temperature sensitive products for medical use, namely, insulated containers designed for transporting and holding radiopharmaceuticals; medical containers specially designed to maintain a consistent internal temperature; temperature controlled packaging specifically adapted for the transportation of pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological (medical) and diagnostic (medical) products; temperature controlled medical containers; refrigerated medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood, blood products, medical supplies, medical products, bio-technological products and diagnostic products; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for dosimetry in the field of radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; apparatus for administering pharmaceuticals; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments; applicators for pharmaceutical preparations; medical apparatus kits for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products; medical apparatus; medical instruments; medical apparatus for diagnostic radiopharmaceutical use; medical instruments for diagnostic radiopharmaceutical use; medical apparatus for diagnostic contrast agent use; medical instruments for diagnostic contrast agent use; medical apparatus for diagnostic tumor-seeking tracer use; medical instruments for diagnostic tumor-seeking tracer use; medical apparatus for diagnostic molecular-imaging probe use; medical instruments for diagnostic molecular-imaging probe use; parts and fittings for the aforesaid goods Provision of medical, health care and wellness (health and nutrition advice) services; provision of medical, health care and wellness (health and nutrition advice) services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical counselling services in the field of treatment, prophylaxis or prevention of medical conditions; psychedelic therapy; psychotherapy; medical treatment and therapy incorporating virtual reality; pharmaceutical advisory services; alternative medicine services; providing medical information in the field of cancer diagnosis; information, support, assistance, consultancy and advisory services in relation to the aforementioned services
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances; pharmaceutical preparations and substances for diagnosis; pharmaceutical preparations and substances for therapy and treatment; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals; radioprotectors; radiopharmaceuticals for use in theranostics; radiopharmaceutical products; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes; radiopharmaceuticals for medical and clinical use; radiopharmaceutical sources and norms for nuclear medicine; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes; diagnostic and therapeutic radioisotopes and radiochemicals for medical purposes; radiopharmaceutical preparations and substances for endo-radionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics in the field of oncology; theranostics in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule; preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material; to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for diagnostic applications; chemicals for pharmaceutical use; chemicals for radiopharmaceuticals for diagnostic uses; pharmaceutical drugs; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; radioactive pharmaceutical preparations; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; implantable radiotherapy devices; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use; positron emission tomography tracers for medical use; positron emission tomography tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; preparations for use in molecular imaging (for medical use); radiotherapeutic preparations; radiodiagnostic preparations; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes; radiopharmaceuticals and radioactive marked substances for therapeutic purposes; solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances for medical imaging; scanning diagnostic reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemicals for medical purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for diagnostic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for therapeutic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for the diagnosis of cancer; drug delivery agents for facilitating delivery of pharmaceutical agents for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals to diagnose and treat cancer; radiopharmaceutical imaging agents for selecting cancer treatments; radiopharmaceutical detection agents for selecting cancer treatments; radiopharmaceutical imaging and detection agents for selecting cancer treatments; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of diseases; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products preparations in the treatment of oncological diseases; tumor-seeking tracers for use in medical imaging; molecular-imaging probes for diagnostic purposes Radiotherapy apparatus and instruments; implantable radioactive sources of radiation; instruments and apparatus for immunotherapy and immuno-diagnostics; medical test equipment; blood analysers; diagnostic devices for medical purposes; electrodes for medical purposes; injection syringes; instrument cases for use by doctors and surgeons; special cases for medical instruments; masks for medical staff; medical apparatus and instruments, namely for the manufacture of radionuclides; pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers for protection against ionising radiation for medical use; insulated containers for temperature sensitive products for medical use, namely, insulated containers designed for transporting and holding radiopharmaceuticals; medical containers specially designed to maintain a consistent internal temperature; temperature controlled packaging specifically adapted for the transportation of pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological (medical) and diagnostic (medical) products; temperature controlled medical containers; refrigerated medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood, blood products, medical supplies, medical products, bio-technological products and diagnostic products; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for dosimetry in the field of radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; apparatus for administering pharmaceuticals; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments; applicators for pharmaceutical preparations; medical apparatus kits for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products; medical apparatus; medical instruments; medical apparatus for diagnostic radiopharmaceutical use; medical instruments for diagnostic radiopharmaceutical use; medical apparatus for diagnostic contrast agent use; medical instruments for diagnostic contrast agent use; medical apparatus for diagnostic tumor-seeking tracer use; medical instruments for diagnostic tumor-seeking tracer use; medical apparatus for diagnostic molecular-imaging probe use; medical instruments for diagnostic molecular-imaging probe use; parts and fittings for the aforesaid goods Provision of medical, health care and wellness (health and nutrition advice) services; provision of medical, health care and wellness (health and nutrition advice) services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical counselling services in the field of treatment, prophylaxis or prevention of medical conditions; psychedelic therapy; psychotherapy; medical treatment and therapy incorporating virtual reality; pharmaceutical advisory services; alternative medicine services; providing medical information in the field of cancer diagnosis; information, support, assistance, consultancy and advisory services in relation to the aforementioned services
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances; pharmaceutical preparations and substances for diagnosis; pharmaceutical preparations and substances for therapy and treatment; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals; radioprotectors; radiopharmaceuticals for use in theranostics; radiopharmaceutical products; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes; radiopharmaceuticals for medical and clinical use; radiopharmaceutical sources and norms for nuclear medicine; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes; diagnostic and therapeutic radioisotopes and radiochemicals for medical purposes; radiopharmaceutical preparations and substances for endo-radionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics in the field of oncology; theranostics in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule; preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material; to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for diagnostic applications; chemicals for pharmaceutical use; chemicals for radiopharmaceuticals for diagnostic uses; pharmaceutical drugs; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; radioactive pharmaceutical preparations; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; implantable radiotherapy devices; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use; positron emission tomography tracers for medical use; positron emission tomography tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; preparations for use in molecular imaging (for medical use); radiotherapeutic preparations; radiodiagnostic preparations; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes; radiopharmaceuticals and radioactive marked substances for therapeutic purposes; solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances for medical imaging; scanning diagnostic reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemicals for medical purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for diagnostic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for therapeutic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for the diagnosis of cancer; drug delivery agents for facilitating delivery of pharmaceutical agents for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals to diagnose and treat cancer; radiopharmaceutical imaging agents for selecting cancer treatments; radiopharmaceutical detection agents for selecting cancer treatments; radiopharmaceutical imaging and detection agents for selecting cancer treatments; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of diseases; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products preparations in the treatment of oncological diseases; tumor-seeking tracers for use in medical imaging; molecular-imaging probes for diagnostic purposes Radiotherapy apparatus and instruments; implantable radioactive sources of radiation; instruments and apparatus for immunotherapy and immuno-diagnostics; medical test equipment; blood analysers; diagnostic devices for medical purposes; electrodes for medical purposes; injection syringes; instrument cases for use by doctors and surgeons; special cases for medical instruments; masks for medical staff; medical apparatus and instruments, namely for the manufacture of radionuclides; pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers for protection against ionising radiation for medical use; insulated containers for temperature sensitive products for medical use, namely, insulated containers designed for transporting and holding radiopharmaceuticals; medical containers specially designed to maintain a consistent internal temperature; temperature controlled packaging specifically adapted for the transportation of pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological (medical) and diagnostic (medical) products; temperature controlled medical containers; refrigerated medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood, blood products, medical supplies, medical products, bio-technological products and diagnostic products; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for dosimetry in the field of radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; apparatus for administering pharmaceuticals; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments; applicators for pharmaceutical preparations; medical apparatus kits for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products; medical apparatus; medical instruments; medical apparatus for diagnostic radiopharmaceutical use; medical instruments for diagnostic radiopharmaceutical use; medical apparatus for diagnostic contrast agent use; medical instruments for diagnostic contrast agent use; medical apparatus for diagnostic tumor-seeking tracer use; medical instruments for diagnostic tumor-seeking tracer use; medical apparatus for diagnostic molecular-imaging probe use; medical instruments for diagnostic molecular-imaging probe use; parts and fittings for the aforesaid goods Provision of medical, health care and wellness (health and nutrition advice) services; provision of medical, health care and wellness (health and nutrition advice) services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical counselling services in the field of treatment, prophylaxis or prevention of medical conditions; psychedelic therapy; psychotherapy; medical treatment and therapy incorporating virtual reality; pharmaceutical advisory services; alternative medicine services; providing medical information in the field of cancer diagnosis; information, support, assistance, consultancy and advisory services in relation to the aforementioned services
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances; pharmaceutical preparations and substances for diagnosis; pharmaceutical preparations and substances for therapy and treatment; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals; radioprotectors; radiopharmaceuticals for use in theranostics; radiopharmaceutical products; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes; radiopharmaceuticals for medical and clinical use; radiopharmaceutical sources and norms for nuclear medicine; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes; diagnostic and therapeutic radioisotopes and radiochemicals for medical purposes; radiopharmaceutical preparations and substances for endo-radionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics in the field of oncology; theranostics in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule; preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material; to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for diagnostic applications; chemicals for pharmaceutical use; chemicals for radiopharmaceuticals for diagnostic uses; pharmaceutical drugs; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; radioactive pharmaceutical preparations; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; implantable radiotherapy devices; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use; positron emission tomography tracers for medical use; positron emission tomography tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; preparations for use in molecular imaging (for medical use); radiotherapeutic preparations; radiodiagnostic preparations; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes; radiopharmaceuticals and radioactive marked substances for therapeutic purposes; solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances for medical imaging; scanning diagnostic reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemicals for medical purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for diagnostic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for therapeutic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for the diagnosis of cancer; drug delivery agents for facilitating delivery of pharmaceutical agents for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals to diagnose and treat cancer; radiopharmaceutical imaging agents for selecting cancer treatments; radiopharmaceutical detection agents for selecting cancer treatments; radiopharmaceutical imaging and detection agents for selecting cancer treatments; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of diseases; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products preparations in the treatment of oncological diseases; tumor-seeking tracers for use in medical imaging; molecular-imaging probes for diagnostic purposes Radiotherapy apparatus and instruments; implantable radioactive sources of radiation; instruments and apparatus for immunotherapy and immuno-diagnostics; medical test equipment; blood analysers; diagnostic devices for medical purposes; electrodes for medical purposes; injection syringes; instrument cases for use by doctors and surgeons; special cases for medical instruments; masks for medical staff; medical apparatus and instruments, namely for the manufacture of radionuclides; pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers for protection against ionising radiation for medical use; insulated containers for temperature sensitive products for medical use, namely, insulated containers designed for transporting and holding radiopharmaceuticals; medical containers specially designed to maintain a consistent internal temperature; temperature controlled packaging specifically adapted for the transportation of pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological (medical) and diagnostic (medical) products; temperature controlled medical containers; refrigerated medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood, blood products, medical supplies, medical products, bio-technological products and diagnostic products; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for dosimetry in the field of radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; apparatus for administering pharmaceuticals; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments; applicators for pharmaceutical preparations; medical apparatus kits for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products; medical apparatus; medical instruments; medical apparatus for diagnostic radiopharmaceutical use; medical instruments for diagnostic radiopharmaceutical use; medical apparatus for diagnostic contrast agent use; medical instruments for diagnostic contrast agent use; medical apparatus for diagnostic tumor-seeking tracer use; medical instruments for diagnostic tumor-seeking tracer use; medical apparatus for diagnostic molecular-imaging probe use; medical instruments for diagnostic molecular-imaging probe use; parts and fittings for the aforesaid goods Provision of medical, health care and wellness (health and nutrition advice) services; provision of medical, health care and wellness (health and nutrition advice) services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical counselling services in the field of treatment, prophylaxis or prevention of medical conditions; psychedelic therapy; psychotherapy; medical treatment and therapy incorporating virtual reality; pharmaceutical advisory services; alternative medicine services; providing medical information in the field of cancer diagnosis; information, support, assistance, consultancy and advisory services in relation to the aforementioned services
5.
RADIOPHARMACEUTICALS, RADIOIMAGING AGENTS, AND USES THEREOF
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The invention also relates to methods of diagnosis, prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
The present invention relates to compounds comprising a metal chelator and two fragments capable of binding to PSMA, compositions thereof and uses thereof in methods of treatment.
The present invention relates to methods of diagnosis and/or radiotherapy, comprising the administration of a compound of Formula (I) and a 64Cu /67Cu radioisotope to deliver a targeted dose of radiation for the diagnosis and treatment of a neuroendocrine cancer, particularly neuroblastoma in children.
The present invention relates generally to methods of diagnosing and/or treating of a cancer associated with overexpression of a PSMA membrane protein, or for reducing PSA levels in a subject. The present invention also relates to radiotherapeutic methods comprising the administration to a subject in need thereof a compound of Formula (I) or a pharmaceutically acceptable salt thereof and a radioisotope to deliver a dose of radiation to a specific site for the treatment of the cancer.
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
The present invention relates to compounds that can complex a radionuclide and formulations and kits comprising compounds that can complex a radionuclide. The compounds, formulations and kits are of use in radiotherapy and diagnostic imaging.
A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
C07B 59/00 - Introduction of isotopes of elements into organic compounds
10.
FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
The present invention is directed to sarcophagine based compounds of formula (I). The compounds can complex a radioisotope, such as 64-copper and hence are useful in radioimaging and radiotherapy of cancers, e.g. colorectal cancer. The compounds work via a pre-targeting imaging approach in which the tetrazine reacts via click chemistry with a functional group such as a transcyclooctene which is pre-bound to a ligand such as a tumour specific antibody.
The present invention is directed to sarcophagine based compounds of formula (I). The compounds can complex a radioisotope, such as 64-copper and hence are useful in radioimaging and radiotherapy of cancers, e.g. colorectal cancer. The compounds work via a pre-targeting imaging approach in which the tetrazine reacts via click chemistry with a functional group such as a transcyclooctene which is pre-bound to a ligand such as a tumour specific antibody.
The present invention relates to methods for the detection and diagnosis of a cancer related to overexpression of prostate-specific membrane antigen (PSMA) by administering a dose of between about 100MBq to about 300 MBq of a 64Cu-labled sarcophagine compound, Sar-bisPSMA, and PET imaging the patient. This method allows for images of greater resolution, even at cancer sites having a lower density of PSMA, such as a secondary lesion.
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
40 - Treatment of materials; recycling, air and water treatment,
10 - Medical apparatus and instruments
42 - Scientific, technological and industrial services, research and design
Goods & Services
Wholesale services featuring pharmaceuticals in the nature of radiopharmaceutical preparations for the treatment and diagnosis of cancers; import-exports agencies in the field of pharmaceuticals in the nature of radiopharmaceutical preparations for the treatment and diagnosis of cancers; promotion and advertising of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, bloodborne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; marketing of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; business intermediary services for the sale and purchase of goods and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; providing an on-line commercial information directory for products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; providing information, consultancy and advisory services in relation to the aforementioned services Radioactive substances for scientific and commercial purposes, namely, radioactive elements for scientific purposes; radioactive elements and isotopes for industrial, scientific and research purposes; radioactive preparations for commercial purposes, namely nuclides and radionuclides, for use in radiographic techniques; radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemical products for radioactive labelling; radiodiagnostic in-vivo agent used for scientific purposes, namely, in-vivo diagnostic agent used for detection and monitoring of carcinogenesis and anti-carcinogenic therapy; radiochemical products for scientific purposes, namely, chemical products for biotechnological product development; radioactive materials for laboratory purposes, namely, radioactive elements, nuclides and radionuclides; radioactive materials for scientific purposes, namely, radioactive elements, nuclides and radionuclides Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics being the use of radioisotopes for the diagnosis and treatment of cancers; radiopharmaceutical preparations for the treatment and diagnosis of cancers; radioprotectors, namely, drugs or compounds that reduce damage to healthy tissue caused by radiation in the course of the diagnosis and treatment of cancers; radiopharmaceuticals for use in theranostics, namely, imaging and detection agents for diagnosing and treating cancers; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical agents for use in PET imaging; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, namely, radiopharmaceuticals for medical and clinical use; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceutical preparations for diagnosing and treating cancer; radiopharmaceutical preparations for the treatment of cancer; radio therapeutic preparations, namely, radio-isotope markers for therapeutic or diagnostic use; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes, namely, radio-isotope markers for therapeutic or diagnostic use; diagnostic and therapeutic radioisotopes and radiochemical preparations for medical purposes, namely, for the treatment of cancers; radiopharmaceutical preparations and substances for endoradionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy, namely diagnostic radiopharmaceutical agent for use in PET imaging; diagnostic radiopharmaceutical preparations and substances for positron emission tomography; diagnostic radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; pharmaceutical preparations in the field of oncology, namely, theranostics drugs for use in the treatment of cancer; pharmaceutical preparations in the field of precision oncology, namely, theranostics drugs for use in the treatment of cancer; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceutical preparations containing radioisotopes for treatment and diagnosis of tumors; target radiopharmaceutical pharmaceuticals containing a target molecule for the treatment of cancers; pharmaceutical preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceutical preparations for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumors, blood-borne tumors, leukemia and melanoma; radiopharmaceutical preparations containing radioisotopes with short half-lives for diagnostic applications; chemical preparations in the nature of radiopharmaceuticals for diagnostic uses; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceutical preparations containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radio-isotope markers, isotopes, preparations and reagents for medical purposes for use in radioactive labelling of cancer cells; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; positron emission tomography tracers for medical use, namely, radioactive isotopes used to label cancer cells; positron emission tomography tracers prepared for ingestion or injection into humans and animals, namely, radioactive isotopes used to label cancer cells; preparations for use in molecular imaging for medical use, namely, radioactive isotopes for in vivo imaging; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiotherapeutic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiodiagnostic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes, namely, radio-isotope markers; diagnostic radiopharmaceutical preparations and radio-isotope markers for therapeutic purposes; pharmaceutical solutions for radioactive labelling; diagnostic imaging agents for magnetic resonance imaging Custom manufacture of pharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radiopharmaceuticals; custom manufacture of radiopharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; providing information, consultancy and advisory services in relation to the aforementioned services Radiotherapy apparatus and instruments; implantable radioactive sources of radiation, namely, implantable radiation therapy devices consisting of radioactive seeds with or without a bioabsorbable carrier assembly; insulated containers especially adapted for temperature sensitive products for medical use, namely, insulated containers especially designed for transporting and holding radiopharmaceuticals; radiation therapy equipment; radioisotope therapy apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for use in treating or diagnosing cancers including via radiotherapy; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; pharmaceutical instruments, namely, radiological apparatus for medical purposes for the treatment of cancer and diseases associated with cellular proliferation; medical apparatus for administering radiopharmaceutical diagnostic products; parts and fittings for the aforesaid goods Pharmaceutical, medicinal, veterinary and therapeutic research and development in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research in the nature of conducting clinical trials for others in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research and development in the field of radiopharmaceuticals and radioprotectors; scientific research and development in the field of theranostics; scientific research and development in the field of radioisotopes suitable for diagnostic and therapeutic medical use; scientific and technological services, namely, scientific research, analysis, testing, and research on radiopharmaceuticals for the diagnosis, therapy and treatment of diseases; engineering services in the field of radiopharmaceuticals and radioisotopes suitable for diagnostic and therapeutic and medical use; scientific research and development of radioisotopes suitable for radiopharmaceuticals; scientific research and development of new procedures and experiments for the discovery, identification or improvement of radioisotopes for radiopharmaceuticals; scientific research and development and engineering services in the field of radioisotopes, radioisotope generators, and linkers suitable for radiopharmaceuticals; scientific research and development in the isolation and capture of radioisotopes suitable for radiopharmaceuticals; scientific research in the nature of conducting clinical trials for others, namely, conducting phase clinical trials with target radiopharmaceuticals; medical research services relating to the development of radiotherapeutics and precision oncology; research, development and testing services relating to radiopharmaceuticals; radio labelling scientific research, namely, labelling of both small molecules and biologics; providing information, advisory and consultancy services in relation to the aforementioned services
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
06 - Common metals and ores; objects made of metal
10 - Medical apparatus and instruments
20 - Furniture and decorative products
35 - Advertising and business services
39 - Transport, packaging, storage and travel services
40 - Treatment of materials; recycling, air and water treatment,
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
45 - Legal and security services; personal services for individuals.
Goods & Services
Radioactive substances for scientific and commercial purposes, namely, radioactive elements for scientific purposes; chemical products for industrial, scientific and research purposes, namely, chemical reagents and chemical preparations for industrial, scientific and research purposes; fissionable chemical elements, namely, chemicals for use in industry and science and chemical substances for analyses in laboratories, other than for medical or veterinary purposes; radioactive elements and isotopes for industrial, scientific and research purposes; radioactive preparations for commercial purposes, namely nuclides and radionuclides, for use in radiographic techniques; radioactive standard preparations in the nature of radionuclides and radioactive elements for the calibration of apparatus and machinery; diagnostic preparations, other than for medical or veterinary purposes; isotopes for industrial purposes; radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemical reagents, other than for medical or veterinary purposes; chemicals for use in the manufacture of radiopharmaceutical products; chemical products for radioactive labelling; radiodiagnostic in-vivo agent used for scientific purposes, namely, in-vivo diagnostic agent used for detection and monitoring of carcinogenesis and anti-carcinogenic therapy; radiochemical products for scientific purposes, namely, chemical products for biotechnological product development; radioactive materials for laboratory purposes, namely, radioactive elements, nuclides and radionuclides; radioactive materials for scientific purposes, namely, radioactive elements, nuclides and radionuclides Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for the treatment of cancers; pharmaceutical preparations and substances for diagnosis of cancers; pharmaceutical preparations and substances for therapy and treatment of cancers; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics being the use of radioisotopes for the diagnosis and treatment of cancers; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; radiopharmaceutical preparations for the treatment and diagnosis of cancers; radioprotectors, namely, drugs or compounds that reduce damage to healthy tissue caused by radiation in the course of the diagnosis and treatment of cancers; radiopharmaceuticals for use in theranostics, namely, imaging and detection agents for diagnosing and treating cancers; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical agents for use in PET imaging; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, namely, radiopharmaceuticals for medical and clinical use; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceutical preparations for diagnosing and treating cancer; radiopharmaceutical preparations for the treatment of cancer; radio therapeutic preparations, namely, radio-isotope markers for therapeutic or diagnostic use; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes, namely, radio-isotope markers for therapeutic or diagnostic use; diagnostic and therapeutic radioisotopes and radiochemical preparations for medical purposes, namely, for the treatment of cancers; radiopharmaceutical preparations and substances for endoradionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy, namely diagnostic radiopharmaceutical agent for use in PET imaging; diagnostic radiopharmaceutical preparations and substances for positron emission tomography; diagnostic radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; pharmaceutical preparations in the field of oncology, namely, theranostics drugs for use in the treatment of cancer; pharmaceutical preparations in the field of precision oncology, namely, theranostics drugs for use in the treatment of cancer; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceutical preparations containing radioisotopes for treatment and diagnosis of tumors; target radiopharmaceutical pharmaceuticals containing a target molecule for the treatment of cancers; pharmaceutical preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceutical preparations for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumors, blood-borne tumors, leukemia and melanoma; radiopharmaceutical preparations containing radioisotopes with short half-lives for diagnostic applications; chemical preparations for pharmaceutical use, namely, for the diagnosis and treatment of cancers; chemical preparations in the nature of radiopharmaceuticals for diagnostic uses; pharmaceutical preparations for the diagnosis of cancers; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceutical preparations containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; chemical preparations for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radio-isotope markers, isotopes, preparations and reagents for medical purposes for use in radioactive labelling of cancer cells; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; positron emission tomography tracers for medical use, namely, radioactive isotopes used to label cancer cells; positron emission tomography tracers prepared for ingestion or injection into humans and animals, namely, radioactive isotopes used to label cancer cells; reagents for medical purposes; preparations for use in molecular imaging for medical use, namely, radioactive isotopes for in vivo imaging; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiotherapeutic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiodiagnostic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes, namely, radio-isotope markers; diagnostic radiopharmaceutical preparations and radio-isotope markers for therapeutic purposes; pharmaceutical solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances in the nature of contrasting agents for medical imaging; diagnostic scanning reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemical preparations and reagents for medical purposes Containers of metal for storage of goods; containers of metal for medical waste; containers of metal for storing and transporting radioactive elements, products and materials; containers of metal for storing and transporting radioactive products; containers of metal for storing and transporting medical goods, apparatus and devices; containers of metal for storing and transporting radiopharmaceuticals, pharmaceuticals, medical goods, apparatus and devices for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; parts and fittings for the aforesaid goods Radiotherapy apparatus and instruments; implantable radioactive sources of radiation, namely, implantable radiation therapy devices consisting of radioactive seeds with or without a bioabsorbable carrier assembly; instruments and apparatus for immunotherapy and immuno-diagnostics; medical devices, namely, blood analyzers; diagnostic devices for medical purposes, namely, medical imaging and detection devices; electrodes for medical purposes; injection syringes; instrument cases fitted for medical instruments for use by doctors and surgeons; special cases fitted for medical instruments; masks for medical staff, namely, surgical masks and protective face masks for medical use; pumps for medical purposes, namely, vacuum pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers especially adapted for protection against ionising radiation for medical use; insulated containers especially adapted for temperature sensitive products for medical use, namely, insulated containers especially designed for transporting and holding radiopharmaceuticals; medical containers especially designed to maintain a consistent internal temperature; temperature controlled packaging specifically adapted for the transportation of pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological medical and diagnostic medical products; temperature controlled medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological medical and diagnostic medical products; refrigerated medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood, blood products, medical supplies, medical products, bio-technological products and diagnostic products; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope therapy apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for use in treating or diagnosing cancers including via radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; medical apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication; medical apparatus for administering radiopharmaceutical diagnostic products; parts and fittings for the aforesaid goods Non-metallic containers, namely, containers for industrial and commercial liquids not made of metal; non-metallic containers for storing and transporting radioactive elements, products and materials; non-metallic containers for storing and transporting radioactive products; non-metallic containers for storing and transporting medical goods, apparatus and devices; non-metallic containers for storing and transporting radiopharmaceuticals, pharmaceuticals, medical goods, apparatus and devices for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, nonHodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; structural foam containers for storage or transport; containers for transport, not of metal; parts and fittings for the aforesaid goods Retail store services featuring pharmaceuticals, pharmaceutical preparations and supplements, medicinal preparations and supplements, medical apparatus and instruments; wholesale store services featuring pharmaceuticals, pharmaceutical preparations and supplements, medicinal preparations and supplements, medical apparatus and instruments; import-exports agencies in the field of pharmaceuticals, pharmaceutical preparations and supplements, medicinal preparations and supplements, medical apparatus and instruments; distribution of advertising materials and samples in the field of pharmaceuticals, pharmaceutical preparations and supplements, medicinal preparations and supplements, medical apparatus and instruments; business administration; business project management; advertising, marketing and promotional services; administration of businesses; business planning; administration relating to business planning; administration relating to marketing; business advisory services; business advisory services relating to product development; business advisory services relating to the management of businesses; business advice relating to advertising; dissemination of advertising material; dissemination of advertising matter; disseminating business, consumer, or commercial information in the field of pharmaceuticals, production and consumption; advertising; consulting services relating to marketing, advertising, promotion, brand development, business strategy, business and brand design, business communications and tracking and analysis of market trends; analysing and compiling business data for marketing intelligence purposes; business analysis services; business administration and management of shareholder and investor relations; providing shareholder business or commercial record keeping and business information and analysis; businesses development, management and operation services in the pharmaceutical and healthcare industries; intermediary business services relating to the commercialisation of goods; technology transfer services (business services); promotion and advertising of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, bloodborne tumours, leukemia and melanoma; marketing of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; business intermediary services for the sale and purchase of goods and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; business information services; providing an on-line commercial information directory for products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; providing advertising information featuring goods and services of others for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma via an on-line searchable database; business advisory services relating to the commercialisation of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; providing information, consultancy and advisory services in relation to the aforementioned services Supply chain logistics and reverse logistics services, namely, storage, transportation and delivery of goods for others by air, rail, ship or truck; supply chain logistics and reverse logistics services, namely, the storage, transportation and delivery of pharmaceuticals, radiopharmaceuticals, pharmaceutical and radiopharmaceuticals products for others by air, rail, ship or truck; packaging for transportation of clinical, pharmaceutical, radiopharmaceutical and health care products to the order and specification of others; leasing of temperature controlled cases for storage and transportation purposes; rental of insulated shipping containers for transporting temperature controlled materials; rental of insulated shipping containers for transporting room temperature, chilled, and frozen materials; providing information, consultancy and advisory services in relation to the aforementioned services Custom manufacture of pharmaceuticals; custom manufacture of pharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radiopharmaceuticals; custom manufacture of radiopharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radioprotectors; custom manufacture of radiotherapy apparatus, devices and instruments; custom manufacture of apparatus, devices and instruments for medical purposes; custom manufacture of apparatus, devices and instruments for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, bloodborne tumours, leukemia and melanoma; providing information, consultancy and advisory services in relation to the aforementioned services Pharmaceutical, medicinal, veterinary and therapeutic research and development; pharmaceutical, medicinal, veterinary and therapeutic research and development in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research and development in the field of radiopharmaceuticals and radioprotectors; scientific research and development in the field of theranostics; scientific research and development in the field of radioisotopes suitable for diagnostic and therapeutic medical use; scientific and technological services, namely, scientific research, analysis, testing, and research on radiopharmaceuticals for the diagnosis, therapy and treatment of diseases; scientific research and development of new procedures and experiments for the discovery, identification or improvement of radioisotopes for medical use; scientific laboratory services; engineering services in the field of radiopharmaceuticals and radioisotopes suitable for diagnostic and therapeutic and medical use; scientific research and development of radioisotopes suitable for radiopharmaceuticals; scientific research and development of new procedures and experiments for the discovery, identification or improvement of radioisotopes for radiopharmaceuticals; scientific research and development and engineering services in the field of radioisotopes, radioisotope generators, and linkers suitable for radiopharmaceuticals; scientific research and development in the isolation and capture of radioisotopes suitable for radiopharmaceuticals; scientific research in the nature of conducting clinical trials in the field of oncology; scientific research in the nature of conducting clinical trials for others, namely, conducting phase clinical trials with target radiopharmaceuticals; medical and scientific research, namely, conducting clinical and pre-clinical trial services for others; pharmaceutical research and development services; testing of pharmaceutical pharmacodynamics, pharmacokinetics and efficacy using a variety of imaging modalities and imaging analysis platforms; imaging services and pathology in support of pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new drugs; scientific investigations for medical research purposes; medical and scientific research laboratory services; medical and scientific research, namely, providing analysis of imaging data obtained from pre-clinical and clinical trial studies; medical and scientific research in the fields of medical radiology imaging, pathology and digital pathology; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; research and development in the fields of medical imaging, pharmaceuticals and biotechnology; research services in the fields of magnetic resonance and molecular imaging; medical research services relating to the development of radiotherapeutics and precision oncology; design, development, maintenance and updating of computer software for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; electronic storage of medical images; processing and analysis of medical images; pathology services in support of drug development; pathology services for preclinical biomarker discovery research and clinical trials; hosting of a medical imaging analysis and visualization platform through a global computer network; hosting of a database of medical images; software as a service (SaaS) featuring computer software platforms for image processing, storage and analysis in the fields of pharmaceuticals, radiopharmaceuticals and biotechnology; conducting clinical trials for others at all stages and in various indications, particularly in oncology, neurology and systemic diseases; imaging contract research organization services and technology solutions, namely, imaging services for medical and scientific research purposes and technology solutions, namely, reviewing of radiology images throughout the clinical trial process and blind independent central review of radiology images in the medical research and clinical trial setting; scientific research services, namely, integration of imaging results with clinical outcome data, with application of machine learning and artificial intelligence applications; development and evaluation of imaging biomarkers for clinical trial purposes; software consulting services in the field of drug discovery; cloud computing featuring software for use in pharmaceutical and radiopharmaceutical drug research in the field of drug discovery; radiochemistry services; research, development and testing services relating to radiopharmaceuticals; radio labelling scientific research, namely, labelling of both small molecules and biologics; providing nondownloadable web-based computer software for database management in the fields of medical research, medical imaging, pharmaceutical, radiopharmaceutical and biotechnology research; research and development of pharmaceuticals, biopharmaceuticals, radiopharmaceuticals, pharmaceutical preparations, medicines, pharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research services, including, providing analytical testing, biosafety testing, reporting and laboratory services for others; preparation of scientific reports; scientific and technical consulting and research services for the pharmaceutical industry; consultation in the field of pharmaceutical drug delivery and dosage technologies; scientific and medical research and product design in relation to positron emission tomography imaging; scientific and medical research and product design in relation to single photon emission tomography imaging; design and development services; design and development of containers for the storage and transport of radioactive materials, radiopharmaceuticals, pharmaceuticals, medical goods, apparatus and devices for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, nonHodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical and scientific research in relation to disease diagnosis; scientific and medical research in relation to molecular imaging; development of molecular imaging products, development of non-medical molecular imaging services; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; providing information, advisory and consultancy services in relation to the aforementioned services Provision of medical, health care, wellness and nutrition services; provision of medical, health care, wellness and nutrition advice services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood- borne tumours, leukemia and melanoma; medical counseling services in the field of treatment, prophylaxis or prevention of medical conditions; mental health therapy services, namely, psychedelic therapy; psychotherapy; medical treatment and therapy incorporating virtual reality; pharmaceutical advisory services; alternative medicine services; providing information, consultancy and advisory services in relation to the aforementioned services Licensing of technology, namely, patent and confidential information licensing of radiopharmaceutical preparations, technologies and apparatus; patent licensing; licensing of intellectual property; legal services relating to the exploitation of intellectual property rights; providing information, consultancy and advisory services in relation to the aforementioned services
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
40 - Treatment of materials; recycling, air and water treatment,
10 - Medical apparatus and instruments
42 - Scientific, technological and industrial services, research and design
Goods & Services
Wholesale services featuring pharmaceuticals in the nature of radiopharmaceutical preparations for the treatment and diagnosis of cancers; import-exports agencies in the field of pharmaceuticals in the nature of radiopharmaceutical preparations for the treatment and diagnosis of cancers; promotion and advertising of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, bloodborne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; marketing of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; business intermediary services for the sale and purchase of goods and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; providing an on-line commercial information directory for products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; providing information, consultancy and advisory services in relation to the aforementioned services Radioactive substances for scientific and commercial purposes, namely, radioactive elements for scientific purposes; radioactive elements and isotopes for industrial, scientific and research purposes; radioactive preparations for commercial purposes, namely nuclides and radionuclides, for use in radiographic techniques; radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemical products for radioactive labelling; radiodiagnostic in-vivo agent used for scientific purposes, namely, in-vivo diagnostic agent used for detection and monitoring of carcinogenesis and anti-carcinogenic therapy; radiochemical products for scientific purposes, namely, chemical products for biotechnological product development; radioactive materials for laboratory purposes, namely, radioactive elements, nuclides and radionuclides; radioactive materials for scientific purposes, namely, radioactive elements, nuclides and radionuclides Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics being the use of radioisotopes for the diagnosis and treatment of cancers; radiopharmaceutical preparations for the treatment and diagnosis of cancers; radioprotectors, namely, drugs or compounds that reduce damage to healthy tissue caused by radiation in the course of the diagnosis and treatment of cancers; radiopharmaceuticals for use in theranostics, namely, imaging and detection agents for diagnosing and treating cancers; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical agents for use in PET imaging; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, namely, radiopharmaceuticals for medical and clinical use; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceutical preparations for diagnosing and treating cancer; radiopharmaceutical preparations for the treatment of cancer; radio therapeutic preparations, namely, radio-isotope markers for therapeutic or diagnostic use; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes, namely, radio-isotope markers for therapeutic or diagnostic use; diagnostic and therapeutic radioisotopes and radiochemical preparations for medical purposes, namely, for the treatment of cancers; radiopharmaceutical preparations and substances for endoradionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy, namely diagnostic radiopharmaceutical agent for use in PET imaging; diagnostic radiopharmaceutical preparations and substances for positron emission tomography; diagnostic radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; pharmaceutical preparations in the field of oncology, namely, theranostics drugs for use in the treatment of cancer; pharmaceutical preparations in the field of precision oncology, namely, theranostics drugs for use in the treatment of cancer; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceutical preparations containing radioisotopes for treatment and diagnosis of tumors; target radiopharmaceutical pharmaceuticals containing a target molecule for the treatment of cancers; pharmaceutical preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceutical preparations for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumors, blood-borne tumors, leukemia and melanoma; radiopharmaceutical preparations containing radioisotopes with short half-lives for diagnostic applications; chemical preparations in the nature of radiopharmaceuticals for diagnostic uses; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceutical preparations containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radio-isotope markers, isotopes, preparations and reagents for medical purposes for use in radioactive labelling of cancer cells; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; positron emission tomography tracers for medical use, namely, radioactive isotopes used to label cancer cells; positron emission tomography tracers prepared for ingestion or injection into humans and animals, namely, radioactive isotopes used to label cancer cells; preparations for use in molecular imaging for medical use, namely, radioactive isotopes for in vivo imaging; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiotherapeutic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiodiagnostic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes, namely, radio-isotope markers; diagnostic radiopharmaceutical preparations and radio-isotope markers for therapeutic purposes; pharmaceutical solutions for radioactive labelling; diagnostic imaging agents for magnetic resonance imaging Custom manufacture of pharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radiopharmaceuticals; custom manufacture of radiopharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; providing information, consultancy and advisory services in relation to the aforementioned services Radiotherapy apparatus and instruments; implantable radioactive sources of radiation, namely, implantable radiation therapy devices consisting of radioactive seeds with or without a bioabsorbable carrier assembly; insulated containers especially adapted for temperature sensitive products for medical use, namely, insulated containers especially designed for transporting and holding radiopharmaceuticals; radiation therapy equipment; radioisotope therapy apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for use in treating or diagnosing cancers including via radiotherapy; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; pharmaceutical instruments, namely, radiological apparatus for medical purposes for the treatment of cancer and diseases associated with cellular proliferation; medical apparatus for administering radiopharmaceutical diagnostic products; parts and fittings for the aforesaid goods Pharmaceutical, medicinal, veterinary and therapeutic research and development in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research in the nature of conducting clinical trials for others in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research and development in the field of radiopharmaceuticals and radioprotectors; scientific research and development in the field of theranostics; scientific research and development in the field of radioisotopes suitable for diagnostic and therapeutic medical use; scientific and technological services, namely, scientific research, analysis, testing, and research on radiopharmaceuticals for the diagnosis, therapy and treatment of diseases; engineering services in the field of radiopharmaceuticals and radioisotopes suitable for diagnostic and therapeutic and medical use; scientific research and development of radioisotopes suitable for radiopharmaceuticals; scientific research and development of new procedures and experiments for the discovery, identification or improvement of radioisotopes for radiopharmaceuticals; scientific research and development and engineering services in the field of radioisotopes, radioisotope generators, and linkers suitable for radiopharmaceuticals; scientific research and development in the isolation and capture of radioisotopes suitable for radiopharmaceuticals; scientific research in the nature of conducting clinical trials for others, namely, conducting phase clinical trials with target radiopharmaceuticals; medical research services relating to the development of radiotherapeutics and precision oncology; research, development and testing services relating to radiopharmaceuticals; radio labelling scientific research, namely, labelling of both small molecules and biologics; providing information, advisory and consultancy services in relation to the aforementioned services
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
40 - Treatment of materials; recycling, air and water treatment,
10 - Medical apparatus and instruments
42 - Scientific, technological and industrial services, research and design
Goods & Services
Wholesale services featuring pharmaceuticals in the nature of radiopharmaceutical preparations for the treatment and diagnosis of cancers; import-exports agencies in the field of pharmaceuticals in the nature of radiopharmaceutical preparations for the treatment and diagnosis of cancers; promotion and advertising of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, bloodborne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; marketing of products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; business intermediary services for the sale and purchase of goods and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; providing an on-line commercial information directory for products and services for the treatment of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma, in the nature of radiopharmaceutical preparations; providing information, consultancy and advisory services in relation to the aforementioned services Radioactive substances for scientific and commercial purposes, namely, radioactive elements for scientific purposes; radioactive elements and isotopes for industrial, scientific and research purposes; radioactive preparations for commercial purposes, namely nuclides and radionuclides, for use in radiographic techniques; radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemical products for radioactive labelling; radiodiagnostic in-vivo agent used for scientific purposes, namely, in-vivo diagnostic agent used for detection and monitoring of carcinogenesis and anti-carcinogenic therapy; radiochemical products for scientific purposes, namely, chemical products for biotechnological product development; radioactive materials for laboratory purposes, namely, radioactive elements, nuclides and radionuclides; radioactive materials for scientific purposes, namely, radioactive elements, nuclides and radionuclides Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics being the use of radioisotopes for the diagnosis and treatment of cancers; radiopharmaceutical preparations for the treatment and diagnosis of cancers; radioprotectors, namely, drugs or compounds that reduce damage to healthy tissue caused by radiation in the course of the diagnosis and treatment of cancers; radiopharmaceuticals for use in theranostics, namely, imaging and detection agents for diagnosing and treating cancers; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical agents for use in PET imaging; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, namely, radiopharmaceuticals for medical and clinical use; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceutical preparations for diagnosing and treating cancer; radiopharmaceutical preparations for the treatment of cancer; radio therapeutic preparations, namely, radio-isotope markers for therapeutic or diagnostic use; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes, namely, radio-isotope markers for therapeutic or diagnostic use; diagnostic and therapeutic radioisotopes and radiochemical preparations for medical purposes, namely, for the treatment of cancers; radiopharmaceutical preparations and substances for endoradionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy, namely diagnostic radiopharmaceutical agent for use in PET imaging; diagnostic radiopharmaceutical preparations and substances for positron emission tomography; diagnostic radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; pharmaceutical preparations in the field of oncology, namely, theranostics drugs for use in the treatment of cancer; pharmaceutical preparations in the field of precision oncology, namely, theranostics drugs for use in the treatment of cancer; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceutical preparations containing radioisotopes for treatment and diagnosis of tumors; target radiopharmaceutical pharmaceuticals containing a target molecule for the treatment of cancers; pharmaceutical preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceutical preparations for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumors, blood-borne tumors, leukemia and melanoma; radiopharmaceutical preparations containing radioisotopes with short half-lives for diagnostic applications; chemical preparations in the nature of radiopharmaceuticals for diagnostic uses; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceutical preparations containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radio-isotope markers, isotopes, preparations and reagents for medical purposes for use in radioactive labelling of cancer cells; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; positron emission tomography tracers for medical use, namely, radioactive isotopes used to label cancer cells; positron emission tomography tracers prepared for ingestion or injection into humans and animals, namely, radioactive isotopes used to label cancer cells; preparations for use in molecular imaging for medical use, namely, radioactive isotopes for in vivo imaging; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiotherapeutic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiodiagnostic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes, namely, radio-isotope markers; diagnostic radiopharmaceutical preparations and radio-isotope markers for therapeutic purposes; pharmaceutical solutions for radioactive labelling; diagnostic imaging agents for magnetic resonance imaging Custom manufacture of pharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radiopharmaceuticals; custom manufacture of radiopharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; providing information, consultancy and advisory services in relation to the aforementioned services Radiotherapy apparatus and instruments; implantable radioactive sources of radiation, namely, implantable radiation therapy devices consisting of radioactive seeds with or without a bioabsorbable carrier assembly; insulated containers especially adapted for temperature sensitive products for medical use, namely, insulated containers especially designed for transporting and holding radiopharmaceuticals; radiation therapy equipment; radioisotope therapy apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for use in treating or diagnosing cancers including via radiotherapy; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; pharmaceutical instruments, namely, radiological apparatus for medical purposes for the treatment of cancer and diseases associated with cellular proliferation; medical apparatus for administering radiopharmaceutical diagnostic products; parts and fittings for the aforesaid goods Pharmaceutical, medicinal, veterinary and therapeutic research and development in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research in the nature of conducting clinical trials for others in relation to radiopharmaceuticals for use in the imaging, diagnosis, treatment and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; scientific research and development in the field of radiopharmaceuticals and radioprotectors; scientific research and development in the field of theranostics; scientific research and development in the field of radioisotopes suitable for diagnostic and therapeutic medical use; scientific and technological services, namely, scientific research, analysis, testing, and research on radiopharmaceuticals for the diagnosis, therapy and treatment of diseases; engineering services in the field of radiopharmaceuticals and radioisotopes suitable for diagnostic and therapeutic and medical use; scientific research and development of radioisotopes suitable for radiopharmaceuticals; scientific research and development of new procedures and experiments for the discovery, identification or improvement of radioisotopes for radiopharmaceuticals; scientific research and development and engineering services in the field of radioisotopes, radioisotope generators, and linkers suitable for radiopharmaceuticals; scientific research and development in the isolation and capture of radioisotopes suitable for radiopharmaceuticals; scientific research in the nature of conducting clinical trials for others, namely, conducting phase clinical trials with target radiopharmaceuticals; medical research services relating to the development of radiotherapeutics and precision oncology; research, development and testing services relating to radiopharmaceuticals; radio labelling scientific research, namely, labelling of both small molecules and biologics; providing information, advisory and consultancy services in relation to the aforementioned services
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for the treatment of cancers; pharmaceutical preparations and substances for diagnosis of cancers; pharmaceutical preparations and substances for therapy and treatment of cancers; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics being the use of radioisotopes for the diagnosis and treatment of cancers; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; radiopharmaceutical preparations for the treatment and diagnosis of cancers; radioprotectors, namely, drugs or compounds that reduce damage to healthy tissue caused by radiation in the course of the diagnosis and treatment of cancers; radiopharmaceuticals for use in theranostics, namely, imaging and detection agents for diagnosing and treating cancers; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical agents for use in PET imaging; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, namely, radiopharmaceuticals for medical and clinical use; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceutical preparations for diagnosing and treating cancer; radiopharmaceutical preparations for the treatment of cancer; radio therapeutic preparations, namely, radio-isotope markers for therapeutic or diagnostic use; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes, namely, radio-isotope markers for therapeutic or diagnostic use; diagnostic and therapeutic radioisotopes and radiochemical preparations for medical purposes, namely, for the treatment of cancers; radiopharmaceutical preparations and substances for endoradionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy, namely diagnostic radiopharmaceutical agent for use in PET imaging; diagnostic radiopharmaceutical preparations and substances for positron emission tomography; diagnostic radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; pharmaceutical preparations in the field of oncology, namely, theranostics drugs for use in the treatment of cancer; pharmaceutical preparations in the field of precision oncology, namely, theranostics drugs for use in the treatment of cancer; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceutical preparations containing radioisotopes for treatment and diagnosis of tumors; target radiopharmaceutical pharmaceuticals containing a target molecule for the treatment of cancers; pharmaceutical preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceutical preparations for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumors, blood-borne tumors, leukemia and melanoma; radiopharmaceutical preparations containing radioisotopes with short half-lives for diagnostic applications; chemical preparations for pharmaceutical use, namely, for the diagnosis and treatment of cancers; chemical preparations in the nature of radiopharmaceuticals for diagnostic uses; pharmaceutical preparations for the diagnosis of cancers; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceutical preparations containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; chemical preparations for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radio-isotope markers, isotopes, preparations and reagents for medical purposes for use in radioactive labelling of cancer cells; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; positron emission tomography tracers for medical use, namely, radioactive isotopes used to label cancer cells; positron emission tomography tracers prepared for ingestion or injection into humans and animals, namely, radioactive isotopes used to label cancer cells; reagents for medical purposes; preparations for use in molecular imaging for medical use, namely, radioactive isotopes for in vivo imaging; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiotherapeutic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; Pharmaceutical preparations and diagnostic preparations for medical purposes, namely, radiodiagnostic preparations used in the application of radioisotopes and radiation in medicine, including nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes, namely, radio-isotope markers; diagnostic radiopharmaceutical preparations and radio-isotope markers for therapeutic purposes; pharmaceutical solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances in the nature of contrasting agents for medical imaging; diagnostic scanning reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemical preparations and reagents for medical purposes
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceuticals and other preparations for medical and veterinary purposes, namely, radioactive pharmaceuticals and radiopharmaceutical preparations for the imaging, diagnosis, treatment and therapy of tumors and cancer
19.
NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
The present invention relates to compounds that inhibit fibroblast activation protein (FAP) and their uses in the treatment, prevention and/or imaging of a cancer associated with the expression of fibroblast activation protein.
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
The present invention relates generally to the identification and/or treatment of cancer and in particular cancers in which gastrin releasing peptide receptor (GRPR) is expressed. In particular embodiments, the present invention relates to the identification and/or treatment of prostate cancer and in particular GRPR expressing metastatic castrate resistance prostate cancer.
C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
G01N 33/534 - Production of labelled immunochemicals with radioactive label
22.
FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING AND USE THEREOF IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES
The present invention relates to formulations of radiolabelled compounds that are of use in radiotherapy and diagnostic imaging. Specifically, the present invention relates to aqueous formulations of 67 Cu radiolabelled compounds of Formula (I) further comprising a buffer, gentisic acid, ethanol and ascorbic acid for use in radiotherapy and diagnostic imaging.
The present invention relates to compounds comprising a metal chelator and two fragments capable of binding to type 2 somatostatin receptors, compositions thereof and uses thereof in methods of treatment.
Radiopharmaceutical compounds of general Formula (I) are based on a sarcophagine cage having a PEG linker-group X through to a group Y capable of binding to a biological receptor and an albumin-binding group Z for the treatment, diagnosis or imaging of diseases including cancer, and the production of such compounds and their complexes.
Radiopharmaceutical compounds of general Formula (I) are based on a sarcophagine cage having a PEG linker-group X through to a group Y capable of binding to a biological receptor and an albumin-binding group Z for the treatment, diagnosis or imaging of diseases including cancer, and the production of such compounds and their complexes.
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The invention also relates to methods of diagnosis, prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
The present invention relates to compounds comprising a metal chelator and two fragments capable of binding to PSMA, compositions thereof and uses thereof in methods of treatment.
The present invention relates to compounds that can complex a radionuclide and formulations and kits comprising compounds that can complex a radionuclide. The compounds, formulations and kits are of use in radiotherapy and diagnostic imaging.
The present invention relates to compounds that are useful as radioimaging agents and radiopharmaceuticals. The compounds may be coordinated with a radionuclide and may be useful in diagnostic imaging and radiotherapy. The invention also relates to methods of prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
The present invention relates to formulations of radiolabeled compounds that are of use in radiotherapy and diagnostic imaging related to prostate specific membrane antigen (PSMA).
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The invention also relates to methods of diagnosis, prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
Radiopharmaceutical compounds of general Formula (I) are based on a sarcophagine cage having a PEG linker-group X through to a group Y capable of binding to a biological receptor and an albumin-binding group Z for the treatment, diagnosis or imaging of diseases including cancer, and the production of such compounds and their complexes.
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The invention also relates to methods of diagnosis, prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as radioimaging agents and radiopharmaceuticals. The compounds may be coordinated with a radionuclide and may be useful in diagnostic imaging and radiotherapy. The invention also relates to methods of prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
The present invention is directed to sarcophagine based compounds of formula (I). The compounds can complex a radioisotope, such as 64-copper and hence are useful in radioimaging and radiotherapy of cancers, e.g. colorectal cancer. The compounds work via a pre-targeting imaging approach in which the tetrazine reacts via click chemistry with a functional group such as a transcyclooctene which is pre-bound to a ligand such as a tumour specific antibody.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 8/00 - Diagnosis using ultrasonic, sonic or infrasonic waves
A61B 10/00 - Instruments for taking body samples for diagnostic purposesOther methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determinationThroat striking implements
Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
A61K 31/495 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
A61K 31/395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
The present invention relates to formulations of radiolabeled compounds that are of use in radiotherapy and diagnostic imaging related to prostate specific membrane antigen (PSMA).
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The invention also relates to methods of diagnosis, prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilizing the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilizing the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which contain a moiety capable of binding to a biological entity and methods of making these compounds. These compounds are of interest as they can be bound to a biological entity and then coordinated with a suitable metallic radionuclide. The coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging.
A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
46.
Cage amine ligands for metallo-radiopharmaceuticals
The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilizing the radiolabelled compounds of the invention.
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.
C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
G01N 33/534 - Production of labelled immunochemicals with radioactive label
50.
FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
The present invention relates to stable formulations of Formula (I), or a salt thereof, complexed with a Cu ion, that are of use in radiotherapy, diagnostic imaging and cancer treatment, wherein the formulations minimize dissociation of the radioisotope from the ligand and/or minimize radiolysis of the ligand arising from the radioisotope.
The present invention relates to formulations of radiolabeled compounds that are of use in radiotherapy and diagnostic imaging related to prostate specific membrane antigen (PSMA). There is provided an aqueous formulation for parenteral administration comprising a compound of Formula (I), or a salt thereof, complexed with a Cu ion, Formulations disclosed herein may include gentisic acid or a salt thereof, and ascorbic acid or a salt thereof. The Cu ion may be a Cu radioisotope.
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
